Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026)
Aura Biosciences' (AURA) quarterly Other Non-Current Assets came in at $517000.0 in Q1 2026, down 32.68% YoY from $768000.0 in Q1 2025, and down 32.68% on a QoQ basis from $768000.0 in Q4 2025.
Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Other Non-Current Assets data on file, last reported at $517000.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 32.68% year-over-year to $517000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $517000.0 (down 32.68% YoY) and the FY2025 annual result came in at $768000.0, up 48.26% from the prior year.
- Other Non-Current Assets fell to $517000.0 in Q1 2026, from $768000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $893000.0 in Q2 2022 to a low of $125000.0 in Q1 2022.
- A 5-year average of $687764.7 and a median of $768000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 614.4% — and 2026, when it tumbled 32.68%.
- Tracing AURA's Other Non-Current Assets over 5 years: stood at $423000.0 in 2022, then jumped by 81.56% to $768000.0 in 2023, then sank by 32.55% to $518000.0 in 2024, then jumped by 48.26% to $768000.0 in 2025, then sank by 32.68% to $517000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $517000.0 (Q1 2026), $768000.0 (Q4 2025), and $768000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 517,000.00 |
| Dec 31, 2025 | 768,000.00 |
| Sep 30, 2025 | 768,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 768,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | 768,000.00 |
| Dec 31, 2023 | 768,000.00 |
| Sep 30, 2023 | 768,000.00 |
| Jun 30, 2023 | 768,000.00 |
| Mar 31, 2023 | 768,000.00 |
| Dec 31, 2022 | 423,000.00 |
| Sep 30, 2022 | 768,000.00 |
| Jun 30, 2022 | 893,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 125,000.00 |